Radella Pharmaceuticals reveals promising Phase 1b trial results for MD-18, showcasing significant weight loss and ...

GLP-1 medication users must consult physicians before surgery to mitigate anesthesia risks and ensure safe pre-operative ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...

Access inequity is driven by operational and bureaucratic challenges, affecting both low-income and developed nations, beyond ...

In May, Pfizer CEO Dr. Albert Bourla defended previous comments HHS officials made about mRNA vaccines. 2 At the time, he called mRNA vaccines the most utilized vaccines in human history. He cited the ...

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...

Modeyso is the first and only approved treatment for recurrent H3 K27M-mutant diffuse midline glioma in patients aged one ...

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with ...

With AI expected to play a significant role in drug approvals, how can companies build data sets that are ready for AI?

The deal brings the FDA-approved neuroblastoma therapy Danyelza (naxitamab-gqgk) to SERB Pharmaceuticals and advances its ...

Ajovy becomes the first-and-only calcitonin gene-related peptide agonist approved for pediatric patients aged six to 17 years ...

The supplemental New Drug Application is supported by data from the Phase II TRANSCEND FL trial (NCT04245839), which showed ...